3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
86
Breast Neoplasms
70
Prostatic Neoplasms
34
Head and Neck Neoplasms
26
Lung Neoplasms
24
Colorectal Neoplasms
24
Ovarian Neoplasms
22
Uterine Cervical Neoplasms
21
Endometrial Neoplasms
16
Brain Neoplasms
15
Rectal Neoplasms
12
Pancreatic Neoplasms
11
Colonic Neoplasms
11
Urinary Bladder Neoplasms
9
Melanoma
9
Lymphoma
9
Leukemia
9
Depression
9
Stomach Neoplasms
8
Pain
8
Motor Activity
8
Colorectal Neoplasms, Hereditary Nonpolyposis
8
Sarcoma
7
Oropharyngeal Neoplasms
7
Multiple Myeloma
7
Hematologic Neoplasms
7
COVID-19
7
Vulvar Neoplasms
6
Health Behavior
6
Glioma
6
Interventions
atezolizumab
5
avelumab
4
erdafitinib
1
enfortumab vedotin
1
darolutamide
1
Therapeutics
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Radiotherapy
1
Patient Reported Outcome Measures
1
Nivolumab
1
Mitomycin
1
Magnetic Resonance Spectroscopy
1
Laparoscopy
1
Immunotherapy
1
Histocompatibility Testing
1
High-Throughput Nucleotide Sequencing
1
Hematologic Tests
1
Gemcitabine
1
Focus Groups
1
Educational Status
1
Drug Therapy
1
Defecation
1
Cytological Techniques
1
Cystoscopy
1
Cisplatin
1
Carboxylesterase
1
Blood Cell Count
1
Biomarkers
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Carcinoma, Transitional Cell
×
Surveys and Questionnaires
×
Clear all
NCT04566029
2025-12-10
AMI
Centre Hospitalier Universitaire de NÄ«mes
Completed
40 enrolled